Affluent Medical SA (FR:AFME) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Affluent Medical has entered into multiple agreements with Edwards Lifesciences, securing a total of EUR 15 million in upfront payments for its mitral valve technologies and an equity stake. The deals include exclusive options, licensing of intellectual property for cardiac valve replacement tech, and a significant investment that makes Edwards a 9.21% shareholder in Affluent. This partnership aims to advance Affluent’s innovative medical devices, including the adjustable mitral ring Kalios™ and Epygon mitral valve.
For further insights into FR:AFME stock, check out TipRanks’ Stock Analysis page.
